William Blair & Company

Kontoor Brands Announces Retirement of Chief Financial Officer Rustin Welton and Appoints Joe Alkire as Successor

Retrieved on: 
Monday, August 21, 2023

Effective August 31, 2023, Joe Alkire will succeed Welton and has been appointed Executive Vice President and Chief Financial Officer.

Key Points: 
  • Effective August 31, 2023, Joe Alkire will succeed Welton and has been appointed Executive Vice President and Chief Financial Officer.
  • Alkire will have responsibility for enterprise strategy, corporate development, financial planning and analysis, accounting, investor relations, tax, treasury, internal audit and information technology.
  • As a member of the company’s Executive Leadership Team, he will report to Kontoor’s President, Chief Executive Officer and Chair of the Board, Scott Baxter.
  • “Joe’s background in our industry and with successful, disruptive brands will help Kontoor continue toward sustained and profitable long-term growth.

Bruker Corporation and PhenomeX Inc. Announce Definitive Agreement for Bruker to Acquire PhenomeX in All-Cash Transaction

Retrieved on: 
Thursday, August 17, 2023

Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction.

Key Points: 
  • Bruker Corporation (Nasdaq: BRKR) and PhenomeX Inc. (Nasdaq: CELL) today announced that they have signed a definitive agreement for Bruker to acquire PhenomeX for $1.00 per share in an all-cash transaction.
  • The proposed acquisition values PhenomeX at a total equity value of approximately $108 million.
  • PhenomeX is a functional cell biology company that provides single-cell biology research tools to deliver deep insights into cellular function and new perspectives on phenomes and genotype-to-phenotype linkages.
  • The PhenomeX products include the key Beacon® Optofluidic platform, as well as the IsoLight® and IsoSpark® proteomics barcoding platform.

Flywire Announces Pricing of Follow-On Offering

Retrieved on: 
Thursday, August 10, 2023

BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”), a global payments enablement and software company, today announced the pricing of its underwritten public offering of 8,000,000 shares of its voting common stock (the “Common Stock”) at a price to the public of $32.00 per share.

Key Points: 
  • BOSTON, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Flywire Corporation (Nasdaq: FLYW) (“Flywire” or the “Company”), a global payments enablement and software company, today announced the pricing of its underwritten public offering of 8,000,000 shares of its voting common stock (the “Common Stock”) at a price to the public of $32.00 per share.
  • Closing of the offering is expected to occur on August 14, 2023, subject to customary closing conditions.
  • In addition, Flywire has granted the underwriters a 30-day option to purchase up to an additional 1,200,000 shares of Common Stock at the public offering price less the underwriting discounts and commissions.
  • J.P. Morgan, Citigroup, BofA Securities, Raymond James, RBC Capital Markets and William Blair are acting as book-running managers for the offering.

Merus Announces Pricing of Public Offering of Common Shares

Retrieved on: 
Thursday, August 10, 2023

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the pricing of an underwritten public offering of 6,818,182 common shares, at a public offering price of $22.00 per share (the “Offer Shares”).

Key Points: 
  • UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the pricing of an underwritten public offering of 6,818,182 common shares, at a public offering price of $22.00 per share (the “Offer Shares”).
  • Merus also granted the underwriters a 30-day option to purchase up to an additional 1,022,727 common shares (the “Option Shares” and together with the Offer Shares, the “Shares”).
  • The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses and excluding the underwriters’ option to purchase the Option Shares, are expected to be approximately $150.0 million.
  • All of the shares in the offering are to be sold by Merus.

Merus N.V. Announces Proposed Public Offering of Common Shares

Retrieved on: 
Wednesday, August 9, 2023

UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of its common shares (the “Offer Shares”).

Key Points: 
  • UTRECHT, The Netherlands and CAMBRIDGE, Mass., Aug. 09, 2023 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq: MRUS) (“Merus”, the “Company,” “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics®), today announced the launch of a proposed underwritten public offering of its common shares (the “Offer Shares”).
  • All of the common shares are being offered by Merus.
  • In addition, Merus expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the Offer Shares (the “Option Shares” and together with the Offer Shares, the “Shares”).
  • The offering is subject to market conditions and other closing conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Fiesta Restaurant Group, Inc. to be Acquired by Authentic Restaurant Brands

Retrieved on: 
Monday, August 7, 2023

ARB is a holding company with a portfolio of powerhouse, iconic regional food and beverage brands, with extraordinary customer brand loyalty and rich, authentic stories.

Key Points: 
  • ARB is a holding company with a portfolio of powerhouse, iconic regional food and beverage brands, with extraordinary customer brand loyalty and rich, authentic stories.
  • Current brands include Primanti Bros Restaurant & Bar, P.J.
  • Upon closing the transaction, Fiesta will operate as a privately held company and Pollo Tropical will remain based in Miami, FL.
  • Houlihan Lokey Capital, Inc. is acting as financial advisor to the Special Committee of the Fiesta Board of Directors.

Consilio Announces Intent to Acquire Lawyers On Demand and SYKE to Bolster Legal Flexible Talent and Advisory Capabilities

Retrieved on: 
Wednesday, August 2, 2023

Consilio, the global leader in legal technology solutions and enterprise legal services, has come to an agreement to acquire Lawyers On Demand (LOD), a pioneer in flexible legal talent, and SYKE, a premier legal technology consultancy headquartered in the UK.

Key Points: 
  • Consilio, the global leader in legal technology solutions and enterprise legal services, has come to an agreement to acquire Lawyers On Demand (LOD), a pioneer in flexible legal talent, and SYKE, a premier legal technology consultancy headquartered in the UK.
  • The practitioners include lawyers, legal engineers, legal operations consultants, paralegals, and risk & compliance professionals across 25 countries.
  • In 2021, LOD began its relationship with SYKE, Europe’s top legal technology consultancy driving legal system implementations, optimization, and commercial contracting services.
  • Rothschild served as financial advisor for LOD and Stephenson Harwood provided legal advice to LOD and SYKE.

D.A. Davidson Strengthens Institutional Equities Team with Three Senior New Hires: Glen Sulam, Kevin DeThomas, and Alex Gamache

Retrieved on: 
Tuesday, July 25, 2023

Davidson & Co. is pleased to announce the hiring of Glen Sulam, Kevin DeThomas, and Alex Gamache by the Equity Capital Markets group.

Key Points: 
  • Davidson & Co. is pleased to announce the hiring of Glen Sulam, Kevin DeThomas, and Alex Gamache by the Equity Capital Markets group.
  • View the full release here: https://www.businesswire.com/news/home/20230725860823/en/
    Based in New York, Glen Sulam serves as D.A.
  • D.A.
  • Davidson is widely recognized for providing timely investment ideas supported by insightful analysis to institutional clients.

VSE Corporation Prices Public Offering of Common Stock

Retrieved on: 
Thursday, July 20, 2023

VSE Corporation (NASDAQ: VSEC; “VSE”, or the “Company”), a leading provider of aftermarket distribution and maintenance, repair and overhaul (“MRO”) services for air, land and sea transportation assets for commercial and government markets, announced today that it has priced its previously announced underwritten public offering of 2,475,000 shares of its common stock at a price to the public of $48.50 per share.

Key Points: 
  • VSE Corporation (NASDAQ: VSEC; “VSE”, or the “Company”), a leading provider of aftermarket distribution and maintenance, repair and overhaul (“MRO”) services for air, land and sea transportation assets for commercial and government markets, announced today that it has priced its previously announced underwritten public offering of 2,475,000 shares of its common stock at a price to the public of $48.50 per share.
  • VSE has also granted the underwriters a 30-day option to purchase up to an additional 371,250 shares of common stock.
  • The offering is expected to close on July 24, 2023, subject to the satisfaction of customary closing conditions.
  • Net proceeds from the offering are expected to be approximately $112.7 million after deducting estimated underwriting discounts and commissions and before estimated offering expenses.

Birch Lake Welcomes Joseph L. Robinson, II as Managing Director

Retrieved on: 
Thursday, July 20, 2023

Birch Lake Holdings, LP (“Birch Lake”), a Chicago-based merchant bank that blends decades of structuring and advisory experience with principal investing, is pleased to announce Joseph L. Robinson, II has joined the firm as its newest Managing Director and member of the investment committee.

Key Points: 
  • Birch Lake Holdings, LP (“Birch Lake”), a Chicago-based merchant bank that blends decades of structuring and advisory experience with principal investing, is pleased to announce Joseph L. Robinson, II has joined the firm as its newest Managing Director and member of the investment committee.
  • View the full release here: https://www.businesswire.com/news/home/20230720979078/en/
    As Managing Director at Birch Lake, Mr. Robinson will play a key role providing strategic advice to business owners, investors, and management teams.
  • Mr. Robinson joins Birch Lake with more than 15 years of advisory experience, particularly in industrials, technology, and real estate.
  • "I am honored to join Birch Lake and work alongside such a talented team," said Mr. Robinson.